Yield10 Bioscience Inc (YTEN) has released an update.
Yield10 Bioscience, Inc. has been granted an additional extension until May 13, 2024, to meet Nasdaq’s listing requirements, particularly regarding stockholders’ equity, after appealing an initial determination of non-compliance. The company is also working to remedy a bid price deficiency by March 25, 2024, where its stock must close at $1.00 or higher for at least 10 consecutive business days. While Yield10 is striving to meet all Nasdaq criteria, there’s no certainty of achieving or maintaining compliance within the given timeframe.
For further insights into YTEN stock, check out TipRanks’ Stock Analysis page.
